Called to find out results of PA from my provider. Spoke with Sierra. She was very helpful and kind. She even called my provider’s office to make sure they had the correct information. Thank you Sierra
Verified User
•
May 6, 2026
2.0/5
2.0/5
Thank you for the consistently kind and helpful customer service. We truly appreciate the way your team cares for your members.This year, we enrolled in a plan very similar to the one we had in 2025. Our son has Type 1 Diabetes and depends on constant medication and medical devices to live. Last year, the prescription coverage made those essentials manageable-specifically, the Dexcom G7 was covered as a Tier 3 medication with an affordable copay. We paid less than $200 per quarter.In 2026, under a very similar plan, the Dexcom G7 remains Tier 3, but there is no financial assistance until we meet a $4,000 prescription deductible. This has increased our cost to approximately $1,100 per quarter. For what is essentially the same coverage, this is a significant and unexpected financial burden.I understand that Select Health does not set the price of the Dexcom. However, coverage decisions directly impact whether families can consistently access it. For children with Type 1 Diabetes, continuous glucose monitoring is not optional-it is essential for safe, daily management.Consistent use of CGMs like the Dexcom G7 is associated with improved A1C levels (often by 0.5-1.0%), which reduces the risk of serious and costly complications. For example, a single hospitalization for diabetic ketoacidosis (DKA) can cost $20,000-$30,000-far exceeding the annual cost of CGM coverage. Better glucose control also lowers the likelihood of long-term complications such as kidney disease, vision loss, and cardiovascular conditions, all of which carry substantial lifetime costs.When access to CGMs becomes financially out of reach, the risk of acute events and long-term complications increases-ultimately leading to higher overall costs for both families and the insurance provider.I urge you to reevaluate how the Dexcom G7 is covered under plans like ours. Supporting consistent access is both a life-preserving measure for patients and a financially responsible decision for Select Health.Thank you for your time and consideration.
Verified User
•
Apr 29, 2026
3.0/5
3.0/5
Very helpful and informative
Verified User
•
Apr 29, 2026
5.0/5
5.0/5
Sierra was very professional. She notified me of what she was going to do when I was on hold. She was very timely responsive. All of my needs were met.
Verified User
•
Apr 28, 2026
3.0/5
3.0/5
They were helpful
Verified User
•
Apr 28, 2026
5.0/5
5.0/5
Wonderful service and was a huge help.
Verified User
•
Apr 28, 2026
5.0/5
5.0/5
Very helpful and got me the answers to my questions which is much appreciated.
Verified User
•
Apr 28, 2026
5.0/5
5.0/5
The lady I spoke to was super helpful. Which was wonderful because this was the second call I had made. The first lady I spoke to was not helpful at all
Called to find out results of PA from my provider. Spoke with Sierra. She was very helpful and kind. She even called my provider’s office to make sure they had the correct information. Thank you Sierra
Verified User
•
May 6, 2026
2.0/5
2.0/5
Thank you for the consistently kind and helpful customer service. We truly appreciate the way your team cares for your members.This year, we enrolled in a plan very similar to the one we had in 2025. Our son has Type 1 Diabetes and depends on constant medication and medical devices to live. Last year, the prescription coverage made those essentials manageable-specifically, the Dexcom G7 was covered as a Tier 3 medication with an affordable copay. We paid less than $200 per quarter.In 2026, under a very similar plan, the Dexcom G7 remains Tier 3, but there is no financial assistance until we meet a $4,000 prescription deductible. This has increased our cost to approximately $1,100 per quarter. For what is essentially the same coverage, this is a significant and unexpected financial burden.I understand that Select Health does not set the price of the Dexcom. However, coverage decisions directly impact whether families can consistently access it. For children with Type 1 Diabetes, continuous glucose monitoring is not optional-it is essential for safe, daily management.Consistent use of CGMs like the Dexcom G7 is associated with improved A1C levels (often by 0.5-1.0%), which reduces the risk of serious and costly complications. For example, a single hospitalization for diabetic ketoacidosis (DKA) can cost $20,000-$30,000-far exceeding the annual cost of CGM coverage. Better glucose control also lowers the likelihood of long-term complications such as kidney disease, vision loss, and cardiovascular conditions, all of which carry substantial lifetime costs.When access to CGMs becomes financially out of reach, the risk of acute events and long-term complications increases-ultimately leading to higher overall costs for both families and the insurance provider.I urge you to reevaluate how the Dexcom G7 is covered under plans like ours. Supporting consistent access is both a life-preserving measure for patients and a financially responsible decision for Select Health.Thank you for your time and consideration.
Verified User
•
Apr 29, 2026
3.0/5
3.0/5
Very helpful and informative
Verified User
•
Apr 29, 2026
5.0/5
5.0/5
Sierra was very professional. She notified me of what she was going to do when I was on hold. She was very timely responsive. All of my needs were met.
Verified User
•
Apr 28, 2026
3.0/5
3.0/5
They were helpful
Verified User
•
Apr 28, 2026
5.0/5
5.0/5
Wonderful service and was a huge help.
Verified User
•
Apr 28, 2026
5.0/5
5.0/5
Very helpful and got me the answers to my questions which is much appreciated.
Verified User
•
Apr 28, 2026
5.0/5
5.0/5
The lady I spoke to was super helpful. Which was wonderful because this was the second call I had made. The first lady I spoke to was not helpful at all